Antibiotic Development: HHS Not Yet Sold On ‘Pull’ Incentives

As HHS develops strategic framework to combat antibiotic resistance, post-market financial incentives may not be included, despite prominent government panels recommending the idea years ago and GAO urging the department to do so in a just-released report. Stakeholders told that GAO reimbursement reform won't be enough to spur a strong antibiotic pipeline.

Competition concept. Business people. Businessmen in suit pull the rope at edge of cliff, symbol of rivalry, competition, conflict. Tug of war. Vector illustration, flat design. Corporate conflicts.
HHS isn't committing to advancing more pull incentives for antibiotics • Source: Shutterstock

The US Health and Human Services agency isn’t ready to go all in on “pull” incentives to encourage the development of new antibiotics, the agency indicated in response to a new Government Accountability Office report.

More from Market Access

More from Pink Sheet